Rapid Micro Biosystems (RPID) Total Liabilities (2020 - 2026)

Rapid Micro Biosystems has disclosed Total Liabilities across 7 years of filings, most recently posting $42.0 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $42.0 million, up 110.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.0 million (up 110.42% YoY), and the FY2025 annual result was $41.6 million, up 82.52% from the prior year.
• Total Liabilities came in at $42.0 million for Q1 2026 at Rapid Micro Biosystems, up from $41.6 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $42.0 million in Q1 2026 to a low of $19.9 million in Q1 2025.
• The 5-year median for Total Liabilities is $22.5 million (2024), against an average of $25.7 million.
• Across the five-year window, Total Liabilities slumped 84.78% in 2022 and surged 110.42% in 2026, its largest moves.
• Rapid Micro Biosystems' Total Liabilities stood at $26.5 million in 2022, then slipped by 3.84% to $25.5 million in 2023, then slipped by 10.39% to $22.8 million in 2024, then jumped by 82.52% to $41.6 million in 2025, then rose by 0.77% to $42.0 million in 2026.
• The last three Total Liabilities figures came in at $42.0 million (Q1 2026), $41.6 million (Q4 2025), and $40.1 million (Q3 2025), per Business Quant data.